Shanghai Yuesai Biotechnology Co., Ltd. announced that it has received over CNY 100 million in round of funding on April 3, 2024. The transaction included the participation from new investors Tasly Pharmaceutical Group Co., Ltd, Shanghai Pudong Venture Investment Co., Ltd. and other investors.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.9 CNY | +0.23% | 0.00% | -24.21% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.21% | 2.66B | |
+12.92% | 4.95B | |
-32.29% | 3.6B | |
-4.28% | 3.03B | |
-8.82% | 2.34B | |
+39.33% | 1.85B | |
+40.81% | 1.45B | |
-14.27% | 1.41B | |
+41.90% | 1.38B | |
-25.47% | 1.31B |
- Stock Market
- Equities
- 600535 Stock
- News Tasly Pharmaceutical Group Co., Ltd
- Shanghai Yuesai Biotechnology Co., Ltd. announced that it has received CNY 100 million in funding from Tasly Pharmaceutical Group Co., Ltd, Shanghai Pudong Venture Investment Co., Ltd. and other investors